• Oncology Pharmacogenetics (PGx) Gene Variation Panel
  • Inhibitor Screen (1:1 Mix), Mixing Studies
  • Acute myeloid leukemia (AML)
  • Bilirubin Total, Serum
  • Coagulation Factor VIII Activity Assay, Plasma
  • The BT-Reveal Early Pancreatic Cancer Test
  • C-Reactive Protein, High Sensitivity (hsCRP)
  • Platelet Function Analysis
  • MSH6 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • Restless legs syndrome
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
Medical Test

References
Access to Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis is restricted.
Loading...